Custom Search

Nabumetone News

Wednesday 07 June 2000

Teva Pharmaceutical Industries Ltd Receives Final FDA Approval of Nabumetone 750mg 180 Days Market Exclusivity Under Paragraph IV

Jerusalem, Israel, - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has received from the US FDA final approval to manufacture and market Nabumetone 750mg Tablets.

[more]

Displaying results 6 to 6 out of 6

< Previous